Cytophage Technologies Ltd. (TSXV:CYTO)
Canada · Delayed Price · Currency is CAD 0.0400
-0.0050 (-11.11%)
At close: Apr 10, 2026
Cytophage Technologies Market Cap
Cytophage Technologies has a market cap or net worth of CAD 2.71 million as of April 10, 2026. Its market cap has decreased by -79.92% in one year.
Market Cap
2.71M
Enterprise Value
3.73M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since February 4, 2022, Cytophage Technologies's market cap has decreased from 5.25M to 2.71M, a decrease of -48.43%. That is a compound annual growth rate of -14.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 2.71M | -73.33% |
| Dec 31, 2025 | 10.15M | -36.19% |
| Dec 31, 2024 | 15.91M | 478.58% |
| Dec 23, 2022 | 2.75M | -47.62% |
| Feb 4, 2022 | 5.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kane Biotech | 5.46M |
| Restart Life Sciences | 5.33M |
| MYND Life Sciences | 5.22M |
| Quest PharmaTech | 5.07M |
| ASEP Medical Holdings | 3.45M |
| Algernon Health | 2.98M |
| BioVaxys Technology | 2.43M |
| Rakovina Therapeutics | 2.01M |